1.
Mean (SD) interval in days between last exposure and testing–second RDT study.
2.
Tobit regression model for exposure-test intervals–PHS Amsterdam MCT subset.
Tobit regression model for the exposure-test intervals–first RDT study.
Tobit regression model for the exposure-test intervals–second RDT study.
R script and aggregated data.
CONSORT 2010 checklist of information to include when reporting a randomised trial*.
Research protocol.
STROBE checklist.
HRs (95% CI) for the association between total MVPA and cardiovascular mortality and incident MACE.
HRs (95% CI) for the association between total MVPA and all-cause mortality.